Survival RatePrognosisSurvival AnalysisRetrospective StudiesFollow-Up StudiesTime FactorsTreatment OutcomePostoperative ComplicationsProspective StudiesAge FactorsKaplan-Meier EstimateCell SurvivalNeoplasm StagingDisease-Free SurvivalSurvivalGraft SurvivalCombined Modality TherapyProportional Hazards ModelsNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsRisk FactorsMultivariate AnalysisLiver NeoplasmsRecurrenceAdenocarcinomaCohort StudiesLymphatic MetastasisActuarial AnalysisLiver TransplantationAntineoplastic AgentsApoptosisChemotherapy, AdjuvantTumor Markers, BiologicalBreast NeoplasmsImmunohistochemistryCisplatinDisease ProgressionCarcinoma, Squamous CellCarcinoma, HepatocellularNeoplasm MetastasisLong-Term CareReoperationDrug Administration ScheduleRegistriesRisk AssessmentStomach NeoplasmsInfant, NewbornRadiotherapy, AdjuvantHepatectomyCyclophosphamideDoxorubicinCarcinoma, Non-Small-Cell LungCell Line, TumorKidney TransplantationMice, Inbred C57BLPredictive Value of TestsFluorouracilSignal TransductionBrain NeoplasmsVincristineGraft RejectionRadiotherapy DosageNeoplasm InvasivenessPancreatic NeoplasmsRemission InductionIncidenceLife TablesDisease Models, AnimalEsophageal NeoplasmsNeoplasmsTransplantation, HomologousCells, CulturedColorectal NeoplasmsAnalysis of VarianceCarcinomaPregnancyTerm BirthDose-Response Relationship, DrugLymph Node ExcisionCell ProliferationImmunosuppressive AgentsGastrectomyPrednisoneMutationJapanChi-Square DistributionTissue DonorsBone NeoplasmsCause of DeathSeverity of Illness IndexNeoadjuvant TherapyRadiotherapyMolecular Sequence DataRNA, MessengerMice, Inbred BALB CHeart ArrestEtoposideSex FactorsBile Duct Neoplasms